| 1. | | Not yet recruiting | Trial of Curcumin in Advanced Pancreatic Cancer
Conditions: Pancreatic Neoplasms; Adenocarcinoma |
| 2. | | Recruiting | A Fish Oil Supplement to Maintain Body Weight in Pancreatic Cancer Patients
Condition: Pancreatic Neoplasms |
| 3. | | Recruiting | Study to treat Cancer-Related Cachexia in Patients with Pancreatic Cancer
Conditions: Pancreatic Neoplasms; Cachexia |
| 4. | | Recruiting | Mistletoe Extract and Gemcitabine for the Treatment of Solid Tumor Cancers
Conditions: Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms |
| 5. | | Recruiting | CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor |
| 6. | | Recruiting | Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
| 7. | | Recruiting | Combination Chemotherapy, Celecoxib, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer |
| 8. | | Recruiting | Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
| 9. | | Recruiting | PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer after Failing a Gemcitabine-Containing Regimen
Condition: Pancreatic Cancer |
| 10. | | Recruiting | 3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
| 11. | | Recruiting | FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor |
| 12. | | Recruiting | Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I, Stage II, or Stage III Adenocarcinoma (Cancer) of the Pancreas
Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; duct cell adenocarcinoma of the pancreas |
| 13. | | Recruiting | Screening For Early Pancreatic Neoplasia in Individuals With Familial Peutz-Jeghers Syndrome and in Relatives of Individuals With Familial Pancreatic Cancer
Condition: Pancreatic Cancer |
| 14. | | Recruiting | Cisplatin, Metronomic Low-Dose Interferon alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer |
| 15. | | Recruiting | Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
Conditions: adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 16. | | Recruiting | 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
| 17. | | Recruiting | Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer |
| 18. | | Recruiting | Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
Conditions: adenocarcinoma of the pancreas; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 19. | | Recruiting | CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer; ... |
| 20. | | Recruiting | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
Conditions: adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 21. | | Recruiting | Chemotherapy, Interferon alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas |
| 22. | | Recruiting | Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 23. | | Recruiting | Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 24. | | Recruiting | Gemcitabine and Radiation Therapy Compared With Observation in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer |
| 25. | | Recruiting | Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage III pancreatic cancer; stage II pancreatic cancer |
| 26. | | Recruiting | Diagnostic and Genetic Study to Identify Pancreatic Lesions in Patients With Von Hippel-Lindau Syndrome
Conditions: Neuroendocrine Carcinoma; Pancreatic Cancer; von Hippel-Lindau Syndrome |
| 27. | | Recruiting | Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas |
| 28. | | Recruiting | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
Conditions: acinar cell adenocarcinoma of the pancreas; duct cell adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; ... |
| 29. | | Recruiting | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas |
| 30. | | Recruiting | Gemcitabine With or Without Radiation Therapy in Treating Patients with Pancreatic Cancer
Conditions: stage III pancreatic cancer; adenocarcinoma of the pancreas |
| 31. | | Recruiting | A study with Gemzar and LY293111 in patients with pancreatic cancer.
Condition: Pancreatic Cancer |
| 32. | | Recruiting | Study of TNFerade™ Biologic with 5-FU and Radiation Therapy for the Treatment of Pancreatic Cancer
Condition: Pancreatic Cancer |
| 33. | | Recruiting | Gene Therapy Combined With Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer That Cannot Be Surgically Removed
Conditions: adenocarcinoma of the pancreas; stage III pancreatic cancer |
| 34. | | Recruiting | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer |
| 35. | | Recruiting | Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients with Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer |
| 36. | | Recruiting | Flavopiridol Plus Radiation Therapy Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer |
| 37. | | Recruiting | Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 38. | | Recruiting | Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: stage III pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 39. | | Recruiting | Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; Pancreatic Cancer; Quality of Life; Thromboembolism |
| 40. | | Recruiting | Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
Conditions: stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 41. | | Recruiting | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas |
| 42. | | Recruiting | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; Drug Toxicity; Pancreatic Cancer |
| 43. | | Recruiting | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
Conditions: Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer |
| 44. | | Recruiting | Laparoscopy to Remove Pancreatic Tumors (Insulinomas)
Condition: Insulinoma |
| 45. | | Recruiting | Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas |
| 46. | | Recruiting | Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
Conditions: recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 47. | | Recruiting | Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
Conditions: Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor |
| 48. | | Recruiting | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer
Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas |
| 49. | | Recruiting | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Conditions: Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer |
| 50. | | Recruiting | Diagnosing and Treating Low Blood Sugar Levels
Conditions: Hypoglycemia; Insulinoma |
